Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05788367
Other study ID # MKSU 50-12-7
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 15, 2023
Est. completion date March 1, 2024

Study information

Verified date September 2023
Source Kafrelsheikh University
Contact Mohammed F Algyar, MD
Phone 00201111645345
Email mohammad.algaiar@med.kfs.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to compare PENG and ISB after shoulder arthroscopy for postoperative pain management after shoulder arthroscopy.


Description:

Shoulder arthroscopy is a common procedure done is orthopedics for many surgical indications as rotator cuff tears, stiffness and instability. This procedure has a well - documented postoperative pain. To improve the outcome after surgery, effective pain control is needed. Various methods are used for postoperative pain management. Intravenous opioid agents are among them, but they may cause undesirable side effects, such as respiratory depression, sedation, constipation, allergic reaction, nausea, and vomiting. Thus, alternative techniques are preferred. Interscalene brachial plexus blocks (ISBPBs) are often used to provide perioperative analgesia and anesthesia for shoulder surgery. They target nerve roots C4-C6 and thereby provide regional analgesia to the shoulder and upper arm. Although ISBPBs are often performed in combination with general anesthesia (GA) to enhance postoperative analgesia, they are also sometimes used as a sole means of anesthesia. The pericapsular nerve group (PENG) block is an ultrasound-guided approach, first described by Giron-Arango et al. for the blockade of the articular branches of the femoral, obturator and accessory obturator nerves that provide sensory innervation to the anterior hip capsule. It has been successfully used as an alternative regional anaesthesia technique for the management of acute pain after hip fracture, and for analgesia after elective hip surgery


Recruitment information / eligibility

Status Recruiting
Enrollment 44
Est. completion date March 1, 2024
Est. primary completion date October 5, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Body mass index < 40 kg/m2 - American Society of Anesthesiologists (ASA) physical status I-II - posted for elective shoulder arthroscopy Exclusion Criteria: - Known allergy to local anesthetics - allergy to all opioid medications - diagnostic shoulder arthroscopic procedures - patients with chronic opioids use and coagulopathy

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
The pericapsular nerve group
patients received Ultrasound guided pericapsular nerve group block using 20 ml of bupivacaine 0.5%
Interscalene brachial plexus block
patients will receive interscalene brachial plexus block using 15 ml of bupivacaine 0.5% before induction of general anesthesia

Locations

Country Name City State
Egypt Mohammed Fouad Mohamed Algyar Kafr Ash Shaykh Kafrelsheikh

Sponsors (1)

Lead Sponsor Collaborator
Kafrelsheikh University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Asses The postoperative opioid consumption the postoperative opioid consumption during the procedure 24 hours postoperatively
See also
  Status Clinical Trial Phase
Completed NCT02291185 - Prediction of Fluid Responsiveness Using Dynamic Preload Indices During Arthroscopic Shoulder Surgery in the Beach Chair Position N/A
Completed NCT02688530 - Intravenous Dexamethasone on Supraclavicular Brachial Plexus Block for Shoulder Arthroscopy Phase 4
Unknown status NCT02178449 - Prolongation of Pain Free Time by the Use of Dexamethasone in Peripheral Nerve Blockade Phase 4
Completed NCT05244525 - Subacromial Injection of Epinephrine Improves Visualization in Shoulder Arthroscopy Phase 4
Recruiting NCT05727345 - Shoulder Anterior Capsular Block and Interscalene Brachial Plexus Block for Shoulder Arthroscopy N/A
Withdrawn NCT01112878 - Oral Clonidine & Gabapentin: Improving Recovery and Pain Management After Outpatient With Major Orthopedic Surgery Phase 4
Enrolling by invitation NCT04610164 - The Effect of Tranexamic Acid (TXA) on Visualization During Shoulder Arthroscopy Phase 3
Completed NCT02181296 - Pulmonary Function and Interscalene Block N/A
Not yet recruiting NCT03216590 - The Effect of Draping on Swelling in Shoulder Arthroscopy N/A
Completed NCT01877330 - Optimal Location of Local Anesthetic Injection for Ultrasound Guided Interscalene Block N/A
Completed NCT01377415 - Continuous Subacromial Bupivacaine N/A
Completed NCT05453266 - Arthroscopic Rotator Cuff Repair Performed With Intraarticular Tranexamic Acid Could it Provide Improved Visual Clarity and Less Post-operative Pain? A Prospective, Double Blind, Randomized Study of 64 Patients. N/A
Completed NCT04566250 - Non-Opioid Prescriptions After Arthroscopic Surgery in Canada (NO PAin) N/A
Recruiting NCT06235879 - Comparison Between Pericapsular Nerve Group (PENG) Block and Interscalene Brachial Plexus Block for Postoperative Analgesia Following Shoulder Arthroscopy N/A
Completed NCT02506660 - Interscalene Block With Low-dose IV vs. Perineural Dexamethasone for Shoulder Arthroscopy Phase 4
Completed NCT01701115 - Effect of Local Anesthetic Dose on Interscalene Block N/A
Completed NCT04483323 - Erector Spinae Plane Block Versus Intraarticular Injection for Postoperative Analgesia in Shoulder Arthroscopy N/A